PURE Bioscience, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PURE research report →
Companywww.purebio.com
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
- CEO
- Robert F. Bartlett
- IPO
- 1996
- Employees
- 11
- HQ
- El Cajon, CA, US
Price Chart
Valuation
- Market Cap
- $7.83M
- P/E
- -3.62
- P/S
- 3.25
- P/B
- -1.25
- EV/EBITDA
- -7.67
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 54139.43%
- Op Margin
- -82.34%
- Net Margin
- -89.78%
- ROE
- 39.74%
- ROIC
- 1548.44%
Growth & Income
- Revenue
- $2.20B · 112075.24%
- Net Income
- $-2,399,000 · 28.39%
- EPS
- $-0.02 · 28.43%
- Op Income
- $-2,272,000
- FCF YoY
- -79512.80%
Performance & Tape
- 52W High
- $0.21
- 52W Low
- $0.04
- 50D MA
- $0.07
- 200D MA
- $0.07
- Beta
- 0.11
- Avg Volume
- 37.28K
Get TickerSpark's AI analysis on PURE
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 17, 25 | Kitchell Jeffrey Scott | other | 0 |
| Nov 17, 25 | Kitchell Jeffrey Scott | other | 45,000 |
| Nov 17, 25 | Kitchell Jeffrey Scott | other | 300,000 |
| Nov 17, 25 | Kitchell Jeffrey Scott | other | 155,000 |
| Nov 17, 25 | Kitchell Jeffrey Scott | other | 45,000 |
| Nov 17, 25 | Kitchell Jeffrey Scott | other | 70,000 |
| Nov 17, 25 | Kitchell Jeffrey Scott | other | 90,000 |
| Nov 17, 25 | Kitchell Jeffrey Scott | other | 150,000 |
| Aug 20, 24 | Myers Thomas Richard | other | 155,000 |
| Aug 20, 24 | Rendall David | other | 125,000 |
Our PURE Coverage
We haven't published any research on PURE yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PURE Report →